A detailed history of Crossvault Capital Management LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Crossvault Capital Management LLC holds 14,285 shares of RANI stock, worth $29,712. This represents 0.06% of its overall portfolio holdings.

Number of Shares
14,285
Holding current value
$29,712
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

BUY
$8.0 - $14.25 $114,280 - $203,561
14,285 New
14,285 $148,000

Others Institutions Holding RANI

About Rani Therapeutics Holdings, Inc.


  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $50.9M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Crossvault Capital Management LLC Portfolio

Follow Crossvault Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossvault Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crossvault Capital Management LLC with notifications on news.